BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

ReVance Therapeutics, Inc. 

2400 Bayshore Parkway, Suite 100

Mountain View  California  94043  U.S.A.
Phone: n/a Fax:


SEARCH JOBS




Industry
Biotechnology

Segment
Start Up





 Company News
ReVance Therapeutics, Inc. (RVNC) Announces Participation In 26th Annual Piper Jaffray Healthcare Conference 11/21/2014 12:37:48 PM
ReVance Therapeutics, Inc. (RVNC) Releases Third Quarter 2014 Results 11/13/2014 9:14:06 AM
ReVance Therapeutics, Inc. (RVNC) Announces Participation In Credit Suisse 2014 Healthcare Conference 11/5/2014 10:09:42 AM
ReVance Therapeutics, Inc. (RVNC) To Release Third Quarter 2014 Financial Results And Host Conference Call On Wednesday, November 12, 2014 10/30/2014 8:01:14 AM
ReVance Therapeutics, Inc. (RVNC) Provides Update On RT001 Clinical Program For The Lead Indication For Crow's Feet Lines 10/2/2014 7:50:29 AM
ReVance Therapeutics, Inc. (RVNC) Announces The Appointment Of Azita Nejad As Vice President Of Quality 9/23/2014 7:38:53 AM
ReVance Therapeutics, Inc. (RVNC) Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 9/3/2014 7:20:37 AM
ReVance Therapeutics, Inc. (RVNC) Appoints Industry Veteran Arthur P. Bertolino, M.D., Ph.D., M.B.A. As Chief Medical Officer 8/12/2014 3:23:34 PM
ReVance Therapeutics, Inc. (RVNC) Releases Second Quarter 2014 Financial Results 8/12/2014 3:19:15 PM
ReVance Therapeutics, Inc. (RVNC) To Release Second Quarter 2014 Financial Results And Host Conference Call On Tuesday, August 12, 2014 7/30/2014 8:05:26 AM
1234